mRNA Vaccines - CISMeF

Preferred Label : mRNA Vaccines;

MeSH definition : Vaccines formulated with recombinant mRNAs which are taken up by the host cells that translate the mRNA and present the translated proteins to the immune system as antigens in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigen.;

MeSH synonym : Messenger RNA Vaccines; mRNA Vaccine; Vaccine, mRNA;

CISMeF synonym : RNA Vaccines;

MeSH Hyperonym : Vaccines, RNA; Naked RNA Vaccines; RNA Vaccine; Vaccine, RNA;

MeSH hyponym : taRNA Vaccine; Vaccine, taRNA; RNA Vaccine, Self-Amplifying; Self Amplifying RNA Vaccine; Vaccine, Self-Amplifying RNA; saRNA Vaccine; Vaccine, saRNA;

Details

Origin ID

D000087503;

UMLS CUI

C5544360;

ATC code(s)
- covid-19, RNA-based vaccine [ATC Code]
ATC code(s)
- covid-19, RNA-based vaccine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- RNA vaccine [COVID-19 Thesaurus concept]
Currated CISMeF NLP mapping
- mRNA Vaccine [NCIt concept]
- mRNA vaccine [COVID-19 Thesaurus concept]
Record concept(s)
- RNA Vaccines [MeSH concept]
- Self-Amplifying RNA Vaccine [MeSH concept]
- Trans Amplifying RNA Vaccine [MeSH concept]
- mRNA Vaccines [MeSH concept]
Related MeSH Supplementary Concept(s)
- ARCT-154 vaccine [MeSH Supplementary Concept]
- CV0501 COVID-19 vaccine [MeSH Supplementary Concept]
- CVnCoV COVID-19 vaccine [MeSH Supplementary Concept]
- GLS-5310 vaccine [MeSH Supplementary Concept]
- GRT-R910 vaccine [MeSH Supplementary Concept]
- LVRNA009 COVID-19 vaccine [MeSH Supplementary Concept]
- MRT5500 vaccine [MeSH Supplementary Concept]
- PTX-COVID19-B COVID-19 vaccine [MeSH Supplementary Concept]
- RQ3013 COVID-19 vaccine [MeSH Supplementary Concept]
- RVM-V001 COVID-19 vaccine [MeSH Supplementary Concept]
- SYS6006 COVID-19 vaccine [MeSH Supplementary Concept]
- Spikevax bivalent zero omicron [MeSH Supplementary Concept]
- famtozinameran [MeSH Supplementary Concept]
- mRNA Vaccine [MeSH Supplementary Concept]
- mRNA-1010 influenza vaccine [MeSH Supplementary Concept]
- mRNA-1073 COVID-19 and influenza combined vaccine [MeSH Supplementary Concept]
- mRNA-1273.214 COVID-19 vaccine [MeSH Supplementary Concept]
- mRNA-1345 respiratory syncytial virus vaccine [MeSH Supplementary Concept]
- mRNA-1647 cytomegalovirus vaccine [MeSH Supplementary Concept]
- repRNA-CoV2S vaccine [MeSH Supplementary Concept]
Semantic type(s)
- Immunologic Factor [UMLS semantic type]
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- mRNA Vaccine [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients